- COVID-19 is primarily infecting older patients with comorbid conditions such as diabetes and cardiac disease.
- Children so far have experienced milder symptoms.
- Pregnant women who have been infected have also had a milder effect.
- The median duration between onset of symptoms and admission to the ICU is around 9 to 10 days.
- Primary reasons for ICU admission have been respiratory support. Two-thirds of patients have met the criteria for ARDS.
- Rapid access to diagnostic testing continues to be a priority as it enables clinicians to take action and implement infection control practices.
- The principal feature of those suffering from serious disease from COVID-10 is the development of ARDS.
- Treatment strategies for such patients include conservative fluid strategies for patients without shock following initial resuscitation, early antibiotics if bacterial co-infection is suspected, lung-protective ventilation, prone positioning, and ECMO for refractory hypoxaemia.
- Septic shock and specific organ dysfunction are also being observed in a significant proportion of patients with COVID-19-related critical illness.
- A large majority of severely affected patients have received targeted therapies, including neuraminidase inhibitors and corticosteroids.
- Mortality among all infected patients remains between 0.5% to 4%, but among those who have to be hospitalised, mortality is around 5 to 15%. Mortality rates are between 22 to 62% among those who become critically ill.
- The exact cause of death remains unknown, but presumed reasons include progressive hypoxia and multiorgan dysfunction.
- Additional critical care strategies are also being implemented including admission of patients with suspected infection to private rooms, use of face masks during assessment and transfer, maintaining a distance of at least 2 m between patients, extra caution when using high-flow nasal oxygen or non-invasive ventilation, and additional airborne precautions including N95 respirators and eye protection.
- Critical care facilities are also ensuring their staff receives updated training in infection prevention and control, including the use of protective equipment.
#CoronavirusOutbreak: Caring for the Critically Ill - Trends, Treatment and Mortality
Published on : Mon, 16 Mar 2020
Intended to establish emergency airway access when endotracheal intubation cannot be performed. Features and benefits Supplied in a slip-peel pouch for easy transportation. The dilators are preinserted into the airway catheters for...
Intended to assist in the placement of an endotracheal tube during difficult or emergency airway access procedures where visualisation of the vocal cords is not possible secondary to secretions, blood and/or anatomic anomalies. Features and...
ExThera’s proprietary Seraph 100 Microbind Affinity Blood Filter (Seraph 100) is a first-of-its kind, CE Marked, technology designed to reduce bloodborne pathogens during bloodstream infections. Validated in preclinical studies and in a clinical trial...
Designed for many applications. Venue is a multi-purpose, point of care system that is also well-suited to help you manage patients in shock. It includes automated tools that enable you to quickly get the information you need to make fast decisions...
Equip Your Lab With More Than 120 Assays in One Integrated System Quality, reliability and value for your lab – making the best labs better. VITROS ® Is Versatile Your lab is under constant pressure to do more. The VITROS ® 5600 features...